Skip to main content

Rangeley Capital, LLC

SEC CIK
0001517796
Latest filing
Aug 14, 2026

TBPH holding history

Theravance Biopharma, Inc. in every 13F filed by Rangeley Capital, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

TBPH overviewAll 13F holders of TBPHFull Q2 2026 holdings

Shares (Q2 2026)
99,500
Value
$1.69M
% of portfolio
1.7%
Quarters held
3
Since Q2 2025
Holdings of TBPH by Rangeley Capital, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202699,500$1.69M1.7%−3,500−3.4%ReducedHolders
Q1 2026103,000$1.67M1.8%+103,000NewHolders
Q3 20250$00.0%−33,729−100.0%Sold outHolders
Q2 202533,729$372.0K0.5%+33,729NewHolders